Related Experiment Video
Updated: Jun 18, 2025

12:43
Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
12.1K
Recent developments in understanding RIG-I's activation and oligomerization
Justyna Sikorska1, Daniel F Wyss1
1Merck & Co., Inc., Rahway, NJ, USA.
Science Progress
|August 2, 2024
Summary
Understanding retinoic acid-inducible gene I (RIG-I) mechanisms is key for immune response. Recent research clarifies RIG-I
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- Immune response activation/inhibition mechanisms are vital for understanding disease pathology.
- Pattern-recognition receptors, like retinoic acid-inducible gene I (RIG-I), differentiate viral from endogenous RNA to initiate antiviral immunity.
- Induction of type I interferons (IFN) is a critical outcome of RIG-I activation.
Purpose of the Study:
- To review recent developments in RIG-I structure and mechanism of action.
- To summarize paradigm-changing research on RIG-I's monomeric and oligomerization states.
- To discuss potential therapeutic applications of modulating the RIG-I pathway.
Main Methods:
- Mini-review of recent scientific literature.
- Focus on structural and mechanistic studies of RIG-I.
- Analysis of research on RIG-I's role in immune signaling.
Main Results:
- Recent work has significantly advanced understanding of RIG-I's structure and function.
- Insights into RIG-I's monomeric and oligomerization states reveal their role in immune response.
- The review synthesizes innovative findings from the past few years.
Conclusions:
- Clarification of long-standing questions surrounding RIG-I function.
- Potential applications for RIG-I pathway modulation in autoimmune diseases and antiviral immunity.
- Enhanced understanding of innate immune sensing pathways.
Related Concept Videos
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
Rab Proteins
3.9K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
3.9K

